Pulmonary alveolar proteinosis is a rare lung disease characterized by abnormal accumulation of lipoproteinaceous material in the alveoli. It was first diagnosed in 1958. The accumulation is caused by a defect in clearance by alveolar macrophages or increased surfactant production. Secondary causes include lung infections, inhalation of toxins, and hematological malignancies. Symptoms vary from asymptomatic to cough, dyspnea, and respiratory failure. Diagnosis involves imaging showing characteristic patterns and analysis of material obtained by bronchoscopy or biopsy showing accumulation of lipoproteins in the alveoli. Treatment options include steroids, whole lung lavage, and treating any underlying causes. Prognosis is generally good with treatment